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Abstract
Rationale:MUC5AC and MUC5B are the predominant gel-forming
mucins in themucus layer of human airways. Eachmucin has distinct
functions and site-specific expression. However, the regional
distribution of expression and cell types that secrete each mucin in
normal/healthy human airways are not fully understood.
Objectives:Tocharacterize the regional distribution ofMUC5Band
MUC5AC in normal/healthy human airways and assess which cell
types produce these mucins, referenced to the club cell secretory
protein (CCSP).
Methods:Multiple airway regions from 16 nonsmoker lungs
without a history of lung disease were studied. MUC5AC, MUC5B,
and CCSP expression/colocalization were assessed by RNA in situ
hybridization and immunohistochemistry in five lungs with
histologically healthy airways. Droplet digital PCR and cell cultures
were performed for absolute quantification ofMUC5AC/5B ratios
and protein secretion, respectively.
Measurements andMain Results: Submucosal glands expressed
MUC5B, but notMUC5AC.However,MUC5Bwas also extensively
expressed in superficial epithelia throughout the airways except
for the terminal bronchioles. Morphometric calculations revealed
that the distal airway superficial epithelium was the predominant
site for MUC5B expression, whereas MUC5AC expression was
concentrated in proximal, cartilaginous airways. RNA in situ
hybridization revealed MUC5AC and MUC5B were colocalized
with CCSP-positive secretory cells in proximal superficial epithelia,
whereasMUC5B and CCSP-copositive cells dominated distal
regions.
Conclusions: In normal/healthy human airways, MUC5B is the
dominant secretory mucin in the superficial epithelium and glands,
with distal airways being a major site of expression. MUC5B and
MUC5ACexpression is a property ofCCSP-positive secretory cells in
superficial airway epithelia.
Keywords: airway mucins; MUC5AC; MUC5B; club cells; distal
airways
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Mucociliary clearance is a critical innate
defense system for maintenance of
lung health. Failed mucus clearance is a
common feature of mucoobstructive lung
diseases, yet how abnormalities in mucus
properties produce intrapulmonary mucus
accumulation remains unclear. Part of this
uncertainty relates to the absence of a
comprehensive formulation that describes
all elements of mucus transport in health.
MUC5AC and MUC5B are the
predominant gel-forming mucins in
human airways (1–4). The classic paradigm
describes MUC5AC secretion in human
airways as a feature of superficial epithelial
goblet cells, whereas MUC5B is predominantly
secreted from submucosal glands (SMG)
(2, 5–8). However, previous data generated
from mice have demonstrated that the
superficial epithelial secretory club cells in
large and small airways produce Muc5b,
which is rapidly secreted in the absence
of Alcian Blue and periodic acid–Schiff
(AB-PAS)-definable mucin granules or
goblet cell morphology (9–13). Moreover,
studies with Muc5b knockout mice
demonstrated that Muc5b was required for
normal lung defense and mucociliary
clearance (14), despite the fact that SMG
in the mice are restricted to the proximal
trachea (15).
Recent studies of normal and diseased
human lungs suggest the murine paradigm
may also be pertinent to the human lung.
Most mucoobstructive diseases (e.g., cystic
fibrosis and chronic obstructive pulmonary
disease) are associated with small airway
mucus plugs that are composed of MUC5B
and MUC5AC (16–18). Importantly,
recent studies of normal and diseased
tissues have established the presence of
MUC5B expression in superficial epithelia,
suggesting distal airway superficial
epithelia may locally secrete the MUC5B
associated with plugging (19–21). Of
particular relevance to small airway
MUC5B expression is the discovery of
the link between MUC5B overexpression
in peripheral airways and idiopathic
pulmonary fibrosis (IPF) (22, 23).
These findings led us to perform
a comprehensive study of region- and
cell-specific expression of MUC5B
and MUC5AC with an emphasis on
comparisons of large airways with
superficial epithelia and SMG versus small
airways lined exclusively with superficial
epithelia. To achieve this aim, multiple
complementary approaches, including
RNA in situ hybridization (ISH),
immunohistochemistry, droplet digital
PCR (ddPCR) quantification, and primary
cell cultures, were used to quantitate
the regional distribution of MUC5B
and MUC5AC expression along the
proximal–distal axis of the normal/healthy
human lung. Based on murine data
(10–14), we also explored the hypothesis
that club cell secretory protein (CCSP)
(also termed secretoglobin 1A member
1)-expressing secretory cells produce
MUC5B, and MUC5AC, in human
superficial airway epithelia. Some of the
results of this study have been previously
reported in the form of abstracts (24, 25).
Methods
For further details on the applied methods,
see the online supplement.
Subjects and Tissue Collection
Lungs that provided airways for study were
obtained from “normal” subjects, defined as
no history of cigarette smoking or lung
disease, who had been maintained on
mechanical ventilation less than or equal
to 7 days as potential lung transplant
donors. Sixteen consecutive lungs (May
2016–March 2018) that were not eligible
for transplant were studied. Table E1 in
the online supplement shows demographics
of the subjects studied. The protocol for
lung dissection was approved by University
of North Carolina Institutional Review
Board. MUC5B promoter variant
rs35705950 genotypes were determined
using TaqMan (Life Technologies)
genotyping (26).
Tissue Preparation,
Immunohistochemistry, and RNA ISH
Excised lungs, obtained from 10 of the 16
normal subjects studied, were dissected to
obtain tracheas, primary bronchi, segmental
bronchi, and lung parenchyma containing
distal bronchi and bronchioles (see Figure
E1). Tissue specimens were fixed, 5-mm
sections cut, and serial sections stained
by hematoxylin and eosin (H&E) and
AB-PAS. Because mechanical ventilation
can induce goblet cell metaplasia and/or
hyperplasia (GMH) in lungs of normal
subjects (i.e., a ventilator-induced
unhealthy state) (27–31), airways were
histologically assessed for “health” by a
pathologist. Five of the 10 lungs were
selected as histologically “healthy” as
defined by volume densities occupied
by mucin-expressing cells in an airway
epithelial region. We term these five
lungs without airway GMH “normal/
healthy.” This definition of normal/
healthy is presented in detail in the
online supplement. MUC5AC, MUC5B,
and CCSP mRNA localization was
assessed by RNA ISH using RNAscope
(Advanced Cell Diagnostics) (see
Figure E2) (32). Protein localization
At a Glance Commentary
Scientific Knowledge on the
Subject: MUC5AC and MUC5B are
the major gel-forming mucins in the
mucus layer of human airways. Each
mucin has a distinct regional
expression. However, a systematic
study of the site- and cell-specific
expression of MUC5B and MUC5AC
in normal/healthy human airways is
not available.
What This Study Adds to the
Field: This study provides a
comprehensive description of
secretory mucin expression in the
normal/healthy human lung essential
for understanding how abnormal
regulation of secretory mucin
expression contributes to the
pathogenesis of mucoobstructive lung
diseases. RNA in situ hybridization
and immunohistochemistry
characterized regional MUC5AC and
MUC5B expression and cell types
expressing these mucins along the
proximal–distal axis of the
normal/healthy human lung. MUC5B
is the dominant secretory mucin in
not only submucosal glands but also
superficial airway epithelia. The distal
airways are a major site of MUC5B
expression and constitute a source of
MUC5B production equivalent in
importance to submucosal glands. The
predominant region for MUC5AC
production is the proximal
(cartilaginous) airway superficial
epithelium. MUC5B and MUC5AC
production are properties of club cell
secretory protein–expressing cells in
both proximal and distal superficial
airway epithelia.
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was assessed by immunohistochemistry
as described (33). Antibodies and RNA
ISH probes are shown in Table E2.
Morphometric Analysis
The airways were classified as: 1) trachea;
2) primary bronchi; 3) segmental bronchi;
4) distal bronchi (.2 mm in diameter);
5) proximal bronchioles (1–2 mm
in diameter); 6) distal bronchioles
(,1 mm in diameter); and 7) terminal
bronchioles, based on airway diameters
and morphology. All histologic sections
were digitally scanned using an Olympus
VS120 microscope. Table E3 shows the
number of airways and the lengths of
basement membrane studied for each
airway region. Volume densities for
mucous glycoproteins, MUC5AC,
MUC5B, and CCSP mRNAs and proteins
within airway superficial epithelia, obtained
from AB-PAS staining, RNA ISH, or
immunohistochemistry, were quantified
by morphometric methods (13, 34–36)
(see Figure E3). The number of cells
expressing target genes was manually
counted to assess gene colocalization
and normalized to airway basement
membrane lengths (see Figure E4).
Calculations of region-specific total mucins
and CCSP mRNA–stained volumes,
using Weibel stereologic parameters
(37, 38), were performed as described
in the METHODS section of the online
supplement (see Table E4).
Absolute Quantification of MUC5AC
and MUC5B Transcript Copy
Numbers in Human Airway Epithelia
Designated airway regions, including
trachea, segmental bronchi, bronchioles,
and peripheral lung parenchyma obtained
from 6 of the 16 normal subjects studied,
were examined for absolute quantification of
MUC5AC and MUC5B transcript copy
numbers by ddPCR (Bio-Rad) (39).
Large and Small Airway Epithelial Cell
Culture
Matched large and small airway epithelial
(LAE and SAE, respectively) cells,
isolated from four lifelong nonsmoker
lungs, were expanded using a modified
conditional reprogramming cell method
(40, 41) to generate well-differentiated
air–liquid interface cultures (see Figure
E5) (42).
Mass Spectrometry
Quantification of MUC5B, MUC5AC, and
surfactant protein B (SFTPB) proteins in
apical washes of LAE and SAE cell cultures
was performed by mass spectrometry
(43, 44).
Statistical Analysis
Statistics were performed using R
version 3.5.1 (R Foundation for
Statistical Computing). Comparison
between two groups was performed by
Wilcoxon rank sum test and comparison
between three or more groups was
performed by Kruskal-Wallis test,
followed by pairwise Wilcoxon
rank sum test for post hoc analysis.
A P value of less than 0.05 was
considered significant.
Results
The Regional Distribution of Mucous
Glycoproteins in Superficial Airway
Epithelium
AB-PAS staining to quantitate airway
regional variations in superficial epithelial
































































































Figure 1. Regional distribution of mucus glycoproteins in superficial airway epithelia from 10 subjects with no prior lung disease history. (A) Hematoxylin
and eosin and Alcian Blue and periodic acid–Schiff (AB-PAS) staining of the superficial epithelium of primary bronchi in (i and ii) a subject with histologically
healthy airways versus (iii and iv) a subject with airway goblet cell metaplasia. (B) Quantification of AB-PAS–positive mucus glycoproteins in airway
superficial epithelium of different airway regions. AB-PAS–stained volume densities in airway superficial epithelium were quantified (n = 10). Each circle
represents AB-PAS–stained volume density for each airway region obtained from subjects with histologically healthy airways (open circles; n = 5; see Ai
and Aii) and subjects with airway goblet cell metaplasia and/or hyperplasia (solid circles; n = 5; see Aiii and Aiv). Mean AB-PAS–stained volume densities in
subjects with histologically healthy airways were compared with those in subjects with airway goblet cell metaplasia and/or hyperplasia by Wilcoxon rank
sum test. Each circle in distal bronchi and bronchioles represent mean values of the AB-PAS–stained volume densities from multiple airways per subject.
No proximal bronchiole was available in one of the five subjects with airway goblet cell metaplasia and/or hyperplasia. Histogram bars and error bars
depict mean6 SD from the 10 subjects. *P, 0.05 and **P, 0.01. BM = basement membrane; H&E = hematoxylin and eosin; NS = not significant. Scale
bars = 50 mm.
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MUC5B and MUC5AC, was performed in
10 lungs (Figure 1). Airway GMH, defined
as an AB-PAS–stained volume density
greater than 0.005 mm3/mm2 per airway
superficial epithelial region (36), was
identified in one or more airway regions in
5 of the 10 subjects. AB-PAS–stained
volume densities in subjects with airway
GMH were generally greater than those in
subjects with histologically healthy airways,
particularly in larger proximal airways
(Figure 1B). Based on the exclusion criteria,
the five subjects without GMH in any
airway region were selected for the RNA





















































Figure 2. Regional distribution of MUC5B and MUC5AC mRNA and protein localization in normal/healthy human airways. Serial sections from five
different regions of airways from one normal/healthy lung were stained by hematoxylin and eosin and Alcian Blue and periodic acid–Schiff, and probed
for MUC5B and MUC5AC by RNA in situ hybridization and immunohistochemistry. Scale bars = 40 mm. For details on the methods of image acquisition,
see QUANTITATION OF MUCOUS GLYCOPROTEINS, MUC5AC, MUC5B, AND CCSP IN AB-PAS, IMMUNOHISTOCHEMISTRY AND RNA ISH in the online supplement. AB-PAS=
Alcian Blue and periodic acid–Schiff; H&E = hematoxylin and eosin; IHC = immunohistochemistry; ISH = in situ hybridization.
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mucin expression as representative of
normal/healthy lungs.
The Regional Distribution of MUC5B
and MUC5AC in Normal/Healthy
Human Airways
RNA ISH and immunohistochemistry
revealed extensive MUC5B, but not
MUC5AC, mRNA, and protein localization
in SMG (Figure 2). Both RNA ISH and
immunohistochemistry demonstrated
significantly greater stained volume
densities for MUC5B, and MUC5AC,
in the superficial epithelium of larger
cartilaginous airways, including the trachea
and bronchi, compared with bronchioles
(Figures 2 and 3; see Figure E6). Notably,
robust MUC5B, but not MUC5AC, mRNA,
and protein staining, were detected in
the distal bronchioles. In the terminal
bronchioles, neither MUC5B nor MUC5AC
was detected.
Two approaches were used to verify the
RNA ISH and immunohistochemistry data
suggesting that MUC5B is the dominant
mucin in bronchioles. First, the relative
sensitivities of the RNA ISH MUC5B versus
MUC5AC probes were tested by comparing
RNA ISH with ddPCR signals in pellets
derived from clustered regularly
interspaced short palindromic repeats
(CRISPR)/CRISPR-associated protein 9–
modified A549 cells expressing MUC5AC
and MUC5B, MUC5AC only, or MUC5B
only. Data from three independent
experiments revealed that the MUC5B
probe exhibited 2.16 0.3-fold increased
sensitivity compared with MUC5AC (see
Figure E7). Adjusting the RNA ISH data by
this factor did not alter the conclusion that
MUC5B was the dominantly expressed
mucin in bronchioles. Second, sections
from large versus small airways were
obtained from six lungs, and ddPCR





























































































































































































































































































































Figure 3. Quantification of MUC5B and MUC5AC mRNAs and proteins in normal/healthy human airway superficial epithelia. (A) MUC5B (i) and MUC5AC
(ii) mRNA–stained volume densities in airway superficial epithelium from normal/healthy lungs were quantified (n = 5). (B) MUC5B (i) and MUC5AC (ii)
protein–stained volume densities by immunohistochemistry were also quantified (n = 5). Histogram bars and error bars represent mean6 SD. Symbols
represent the five distinct subjects. For distal bronchi and bronchioles, more than one airway per region was examined per subject. BM = basement
membrane; ISH = in situ hybridization.
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was performed to compare MUC5B with
MUC5AC transcript copy number in each
airway region (Figure 4A). Absolute
quantification of MUC5B and MUC5AC
transcripts revealed that MUC5B
normalized to GAPDH (MUC5B/
GAPDH) was not different from MUC5AC/
GAPDH in the larger cartilaginous
airways, including trachea and bronchi.
In contrast, MUC5B/GAPDH was
significantly greater than MUC5AC/
GAPDH in bronchioles (Figure 4B).
Based on the MUC5AC/MUC5B ratio
(Figure 4C), MUC5B transcript copy
number was 20-fold higher than MUC5AC
in bronchioles, consistent with RNA
ISH/immunohistochemistry data.
What Cell Type Expresses MUC5B
and MUC5AC mRNAs in
Normal/Healthy Human Large and
Small Airways?
Based on mouse airway data (10–14),
CCSP1 secretory cells were identified as
candidates for secretory mucin expression
in normal/healthy human airways. Both
RNA ISH and immunohistochemistry
demonstrated widespread superficial
epithelial localization of CCSP mRNA and
protein from the trachea to the terminal
bronchioles (Figures 5A–5D; see Figure E8).
With respect to SMG, CCSP mRNAs were
expressed in the ciliated ducts but not
collecting ducts nor acini (Figures 5E and
5F). In contrast, MUC5B mRNAs were
localized throughout all SMG epithelial
structures. Quantification of CCSP
mRNA–stained volume densities revealed
robust expression in the segmental, distal
bronchi, and bronchioles compared with
trachea or primary bronchi (Figure 5G).
Quantitative colocalization studies
were performed using fluorescent RNA ISH
in five normal/healthy lungs (Figure 6).
Typical goblet cells, characterized by AB-
PAS–positive large secretory vesicles filling
the cytoplasm, were rarely identified in
superficial epithelia of these subjects
(Figure 6Bii). In contrast, SMG consistently
exhibited mucous cells with AB-PAS–
definable large mucin granules (Figure 6Aii).
Human airway cells expressing
MUC5AC, MUC5B, CCSP mRNAs, or
a combination of these markers were
classified into the seven possible types
(see Table E5). Four distinct, region-
specific dominant cell types were identified
among the seven possible types. First,
CCSP2/MUC5B1/MUC5AC2 cells
were routinely found in SMG yet rarely,
if at all, in superficial epithelia. Second,
CCSP1/MUC5B1/MUC5AC1 cells were the
dominant cell type in primary bronchial
superficial epithelia. In this region, H&E and
AB-PAS staining identified two nonciliated
epithelial cell types: a nonciliated epithelial
cell that had an AB-PAS–stained apical
bulge protruding into the airway lumen; and
a cell with apical cell membranes at the same
height as those of adjacent ciliated cells
without an apical bulge (Figures 6Bi and
6Bii). CCSP1/MUC5B1/MUC5AC1 cells
exhibited morphologies similar to both cell
types (Figure 6Bvii; see Figure E9). The
number of CCSP1/MUC5B1/MUC5AC1
cells dramatically decreased in the
bronchioles, and virtually disappeared in
the terminal bronchioles, paralleling the
decreased volume densities of MUC5AC
mRNA and protein (Figure 3). Third,
CCSP1/MUC5B1/MUC5AC2 cells were the
dominant cell type in the distal bronchiolar
superficial epithelium. H&E staining
identified nonciliated epithelial cells with
dome-shaped apical bulges, which
morphologically corresponded to the
CCSP1/MUC5B1/MUC5AC2 cells (Figures
6Ci and 6Cvii). Finally, although a small
number of CCSP1/MUC5B1/MUC5AC2
cells were detected, CCSP1/MUC5B2/
MUC5AC2 cells were the dominant cell type
in the terminal bronchioles. Of note,
CCSP1/MUC5B2 cells in superficial
epithelia of terminal bronchioles uniquely
expressed SFTPB, which is known as a distal
airway marker (see Figure E10) (45).
Primary Human SAE Cells Secrete
MUC5B Protein In Vitro
Based on the reported distinct progenitor
cell properties of large versus distal airway
epithelial cells (40, 45, 46), we used an SAE
versus LAE cell culture technique to test
whether MUC5B protein was locally
produced by small airway epithelia as
predicted by in vivo RNA ISH and
immunohistochemistry data. H&E staining
























































Trachea Bronchi Bronchiole Alveoli
Figure 4. Droplet digital PCR quantification of MUC5B and MUC5AC transcript copy numbers in
freshly isolated human airway epithelium from subjects with no prior lung disease history. (A)
Examples of dissected airway tissues including a trachea, bronchus, bronchiole, and peripheral
lung parenchyma. (B) Absolute transcript copy numbers in different airway regions for MUC5B
(circles) and MUC5AC (triangles). (C) MUC5AC/MUC5B ratios in each airway region. Measurements
in B and C were performed by droplet digital PCR, with absolute MUC5B or MUC5AC transcript
copy numbers normalized to GAPDH and shown as target/GAPDH ratios. Histogram bars and error
bars represent mean6 SD. n = 6. Different symbol colors indicate results from six distinct individual
subjects. **P, 0.01 by Wilcoxon rank sum test. NS = not significant.
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cultures versus stratified multilayers in LAE
cells (Figures 7Ai and 7Aii), consistent with
in vivo morphologic features of large versus
small airway epithelia in human lungs (47,
48). As a distal airway marker (45), SFTPB
was detected by quantitative PCR and mass
spectrometry in SAE but not LAE cultured
cells (Figures 7B and 7D). These findings
indicate that our in vitro SAE cell culture
model retained characteristics of distal
airways distinguishable from large airways.
RNA ISH showed MUC5B mRNA
localization in CCSP mRNA1 nonciliated
secretory cells in both LAE and SAE cells
(Figures 7Aiii–7Avi). Both Western
blotting and mass spectrometry identified
MUC5B protein in apical washes of SAE
cells (Figures 7C and 7E), although less
than secreted by LAE cells. In apical
washes obtained from SAE cells, the
concentration of MUC5B protein (6.046
5.95 pmol/ml) was 9.2-fold higher than

























































































Figure 5. Regional distribution of CCSP mRNA localization in normal/healthy human airways. Representative CCSP mRNA localization from one
normal/healthy lung stained by RNA in situ hybridization (ISH) in (A) trachea, (B) primary bronchus, (C) segmental bronchus, and (D) distal lung parenchyma
containing distal bronchi and bronchioles. (E) CCSP andMUC5B mRNA localization stained by RNA ISH in normal/healthy tracheal submucosal gland ducts.
CCSP (red) mRNA signals stop in the middle of the submucosal gland ducts (arrows) with MUC5B (teal) mRNA signals being expressed throughout the
submucosal gland ducts. (F) CCSP and MUC5B mRNA localization costained using RNA ISH in the normal/healthy tracheal superficial epithelium and
submucosal glands acini. (G) Quantification of CCSP mRNA–stained volume densities in normal/healthy human airway superficial epithelium (n = 5). CCSP
mRNA–stained volume densities by RNA ISH were quantified. Histogram bars and error bars represent mean6 SD. Symbols represent the five distinct
subjects. For distal bronchi and bronchioles, more than one airway per region was examined per subject. BM= basement membrane; CCSP= club cell
secretory protein; SE= superficial epithelium; SMG-A = submucosal glands acini; SMG-D= submucosal gland ducts; TB = terminal bronchiole.
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A B C D
E i ii iii iv
Figure 6. MUC5B, MUC5AC, and CCSP mRNA coexpression is region-specific. (A–D) Colocalization of MUC5B and MUC5AC with CCSP mRNAs by
RNA in situ hybridization (ISH) in four different regions of normal/healthy human airways. For cellular localization, MUC5B (green), MUC5AC (red),
and CCSP (white) mRNAs were visualized by fluorescent RNA ISH. Single-color images were merged (Avi–Dvi, “overlay”) and the overlaid images
superimposed on differential interference contrast (Avii–Dvii). In submucosal glands (A), mucus cells exhibited large mucin granules definable by Alcian
Blue and periodic acid–Schiff (AB-PAS) staining (insets in Ai and Aii). In primary bronchial superficial epithelium (B), two nonciliated epithelial cell types were
identified: 1) a nonciliated epithelial cell with an AB-PAS–stained apical bulge (Bi, Bii, and Bvii, black arrowheads) and 2) a nonciliated epithelial cell without
the apical bulge (Bi, Bii, and Bvii, white arrowheads). In distal bronchioles (C), nonciliated epithelial cells with dome-shaped apical bulges (Ci and Cii, black
arrows) corresponded to the CCSP1/MUC5B1/MUC5AC2 cells (Cvii, white arrows). Nuclei were stained with DAPI (blue). Scale bars = 20 mm. (E)
Quantification of cell types expressingMUC5B,MUC5AC, and/or CCSPmRNAs in different regions of normal/healthy human airways. Data are expressed
as the number of each cell type per millimeter of basement membrane. Solid bars and error bars represent mean6 SD. n = 5. *P, 0.05 compared with
every other cell type by pairwise Wilcoxon rank sum test for post hoc analysis, following significant Kruskal-Wallis test. BM = basement membrane;
CCSP = club cell secretory protein; DIC = differential interference contrast; H&E = hematoxylin and eosin; SMG= submucosal glands.
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Region-Specific Superficial Epithelial
Mucin Production in Normal/Healthy
Human Lungs
To describe the airway regions contributing
to total MUC5AC and MUC5B expression
in the lung, the numbers, diameters,
and total surface areas of airways as reported
by Weibel and coworkers (37, 38) were used
to calculate: total MUC5B, MUC5AC, or
CCSP mRNA–stained volumes for the
superficial epithelium of each airway region
based on RNA ISH; and the percent of
total MUC5B, MUC5AC, and CCSP
mRNA–stained volumes for each airway
region (Figure 8; see Table E4).
MUC5B mRNA–stained volume
in airway superficial epithelia increased
from the proximal to the distal airways,
reflecting the exponential increase in
distal airway surface area. MUC5B
mRNA–stained volume peaked in the
distal bronchioles with a threefold higher
value than observed in the cartilaginous
large airways. In contrast, MUC5AC
mRNA–stained volume peaked in the distal
bronchi. Even though the combined surface
area of proximal and distal bronchioles is
more than 30-fold greater than distal
bronchi, the percent of MUC5AC
mRNA–stained volumes in bronchioles was
less than distal bronchi. Importantly, both
MUC5B and MUC5AC mRNA–stained
volumes were negligible in the terminal
bronchioles despite the fact that terminal
bronchiolar surface area is the largest of the
airway regions. For reference, CCSP
mRNA–stained volume increased as a
function of more distal regions and peaked
in the terminal bronchioles.
Discussion
A comprehensive regional expression
pattern of MUC5B and MUC5AC in
normal/healthy human lungs has not been
reported. Recent data from mice airways
suggest that Muc5b is secreted by superficial
epithelial club cells in both larger airways
and bronchioles (9–12). Whether this
paradigm pertains to normal/healthy
human airways was the focus of this study.
It is difficult to obtain intact normal/
healthy human lungs for studies of regional
mucin expression. We adopted the criteria
that a normal/healthy lung region had to be
obtained from a lung donor: 1) without
history of lung disease or smoking; 2)






















































































Figure 7. MUC5B production in primary human small airway epithelial cell cultures. (A) Histologic images
of large and small airway epithelial cell cultures. Air–liquid interface cultures of large airway epithelial (LAE)
and small airway epithelial (SAE) cells were stained by hematoxylin and eosin (i and ii) and RNA in situ
hybridization for MUC5B (iii and iv) and CCSP mRNAs (v and vi). MUC5B mRNAs (green) are localized in
CCSP mRNA (red)–positive nonciliated cells in both LAE and SAE cells (v and vi, white arrows). Scale
bars =10 mm. (B) SFTPB transcript expression in LAE and SAE cells. SFTPB gene was specifically
detected in SAE but not LAE cells by quantitative PCR. GAPDH was used as the reference gene.
(C) Identification of MUC5B protein in apical washes of LAE and SAE cells. Immunoblots of apical
washes were probed with antibody to MUC5B. Samples from both LAE and SAE cell cultures were
run on the same gel. (D) Quantification of SFTPB protein in apical washes of LAE and SAE cells.
SFTPB protein was identified by mass spectrometry (MS) using label-free quantification normalized to
total precursor intensity. (E) Absolute concentrations of MUC5B protein in apical washes of LAE and
SAE cells as determined by MS. (F) Absolute mucin concentrations for both MUC5B and MUC5AC in
apical washes of SAE cells as determined by MS. B and C: n=3, the order of three biologic replicates
were the same in B andC. D and E: Histogram bars and error bars represent mean6 SD. n=4, *P, 0.05
by Wilcoxon rank sum test. CCSP= club cell secretory protein; DIC =differential interference contrast;
H&E= hematoxylin and eosin; ISH = in situ hybridization.
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than or equal to 7 days; and 3) did not
exhibit GMH as defined by more than
0.005 mm3/mm2 AB-PAS–stained volume
density in a superficial epithelial region,
based on the mean value of mucin volume
densities in healthy subject group in
transbronchial biopsy study (36). Using
these criteria, 5 of the 10 lungs from study
subjects met the criteria for normal/healthy
lungs. We speculate that the five subjects
that exhibited airway GMH were more
sensitive to the stresses of the mechanical
ventilation, which has been shown to
rapidly induce GMH in primary human cell
culture models, animal models, and
preterm infants (27–31). If indeed the
excluded lungs were normal/healthy before
mechanical ventilation, our data may
document how rapidly and substantially
large airway GMH can be induced by
mechanical stresses (Figure 1B).
Our results demonstrate that MUC5B
is extensively expressed in the superficial
epithelium, in addition to SMG, of
normal/healthy human airways.
Importantly, these findings indicate that a
major site for MUC5B production is the
small airway superficial epithelia where
SMG do not exist (Figure 8). These findings
are consistent with the results of RNA-seq
quantification of the normal human SAE
transcriptome (49), and studies describing
high expression of MUC5B versus MUC5AC
in normal distal airway epithelium (21).
Our studies permitted a semiquantitative
description of the relative expression of
MUC5B in the SMG versus small airways
of the normal/healthy human lung. In the
large airways (e.g., from trachea to sixth
generation bronchi) SMG occupy a volume
of z0.10 mm3/mm2 airway surface area in
nonsmokers (50), and the mucous cell
percentage of total SMG volume is about
40% (51, 52). Based on these numbers and
regional airway surface areas (37, 38) (see
Table E6), the MUC5B mRNA–stained
volume in distal bronchiolar superficial
epithelia exceeded the total mucin volume
of the SMG (see Figure E11). Although it is
difficult to predict secretion rates based on
stained volumes, the superficial epithelium
of small airways may be considered a
source of MUC5B production at least equal
to SMG.
Interestingly, the SMG and superficial
epithelium provide redundant sources for
MUC5B in central airway locations. One
unresolved issue is whether the superficial
epithelium provides the basal MUC5B
secretion in this region, as it likely does
in mice (10, 11), with SMG providing
intermittent secretion to acutely trap
inhaled irritants that provoke cough
responses. A second unresolved issue with
regard to MUC5B biology in the large
airways is whether superficial epithelial
MUC5B differs from gland-derived
MUC5B. Differences may occur because
MUC5B seems to be secreted in large
airways from different cell types. A CCSP-
positive cell without definable granules
secretes MUC5B in the superficial
epithelium, whereas MUC5B is secreted in
SMG from CCSP-negative cells with large
mucin storage granules. MUC5B is known
to exist as two glycoforms with different
charges, a low and a high charge, and the
low-charge MUC5B is elevated in the
sputum from the subjects with asthma, cystic
fibrosis, and chronic obstructive pulmonary
disease (3, 53). Further studies are required
to determine whether MUC5B glycan-based
charge differs in MUC5B secreted by SMG
versus the superficial epithelium.
Our results revealed that neither
MUC5B nor MUC5AC is expressed in
terminal bronchioles. This finding was also
apparent in the group of five subjects with
airway GMH (Figure 1B). Interestingly, this
finding mimics the absence of Muc5b
expression reported in terminal bronchioles
of mice (10). Moreover, it is notable that
a subtype of CCSP1 cells exists in the
terminal bronchioles that do not express
MUC5B but do express SFTPB (see Figure
E10), consistent with previous RNA ISH
findings (54). These data are consistent
with reports that SFTPB and mucin gene
expression are inversely regulated through
NK2 homeobox1 at the transcription
level (55–57). The finding that secretory
mucins are not expressed in terminal
bronchioles suggests that the physiology of
terminal bronchioles requires a surfactant-
rich, mucin-free zone to protect gas
exchange functions in alveoli adjacent to
terminal bronchioles. Because MUC5B
overexpression in peripheral airways is
reported in patients with IPF (21–23), it is
possible that the loss of a surfactant-rich
terminal bronchiolar mucin-free zone is
associated with IPF pathogenesis.
In contrast to MUC5B, which is necessary
to sustainmucociliary clearance (14),MUC5AC
has been recognized as a “response mucin”
with expression regulated by several
inflammatory stimuli (9, 19, 29). The highly
responsive nature of MUC5AC suggests that it
provides critical innate immune functions
during airway stresses. Our study revealed that
MUC5AC-stained volume density peaked at
the level of segmental bronchi. Maximal
deposition of particles greater than 1 mm
diameter per unit surface area occurs in this
region (58), suggesting that MUC5AC is
responding to the load of external stimuli
deposited in this region. Importantly, it seemed
that MUC5AC expression was superimposed
on MUC5B/CCSP-expressing cells; and
as MUC5AC expression increased, the
cell morphology appeared more goblet cell–like.
The RNA ISH approach identified four
distinct types of airway secretory cells based
on the combination of MUC5AC, MUC5B,
and CCSP transcript expression. Each cell-
type predominantly exists in different airway












































Figure 8. Distinct regional distributions of MUC5AC, MUC5B, and CCSP mRNA localization in
superficial epithelium of the normal/healthy lung. Data represent the calculated percent of total
MUC5AC, MUC5B, or CCSP mRNA–stained volumes for each airway region. Total MUC5AC,
MUC5B, or CCSP mRNA–stained volume for each airway region was calculated by multiplying the
mean values of the RNA in situ hybridization volume densities for each airway region obtained from
five normal/healthy lungs by predicted total surface area of corresponding airway regions. CCSP =
club cell secretory protein.
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epithelium (Figure 6). Airway surface
secretory epithelial cells have conventionally
been divided into four distinct cell types
based on morphology and ultrastructure:
1) mucous (goblet), 2) serous, 3) club
(Clara), and 4) neuroendocrine cells (59).
Mucous cells are mainly located in the
tracheobronchial tree and rarely in
bronchioles (60). Serous cells have been
described in surface epithelium in adult
human small bronchi and bronchioles,
whereas club cells have been considered to
be the predominant secretory cell type in the
human bronchiole (61). Juxtaposing these
data to our results, CCSP was shown to be
expressed not only in typical club cells in
distal airways but also nonciliated airway
secretory cells in large airway superficial
epithelia. The CCSP mRNA1 cells typically
expressed MUC5B/MUC5AC mRNAs in
large airway epithelia and MUC5B mRNAs
in small airway epithelia. Thus, a subset of
CCSP1 cells seems to define a mucin
secretory cell type in superficial epithelia.
Consistent with our findings, single-
cell transcriptome analysis of human
airway epithelial club cells revealed that
a subset of CCSP1 cells coexpressed
MUC5B/MUC5AC, indicating possible
lineage relationship between CCSP1
secretory cells and mucin-secreting cells in
human airways (62). In contrast, MUC5B-
producing cells in SMG may reflect a
different lineage because CCSP expression
was absent in SMG mucous cells.
Morphologically, CCSP1/MUC5B1/
MUC5AC2 cells in distal airways resembled
typical club cells, whereas the morphology
of CCSP1/MUC5B1/MUC5AC1 cells in
proximal larger airways was variable,
reflecting club cells and cells that were
termed “mucous cells,” “serous cells,” or
“indeterminate cells” (63, 64). Our data
suggest that the current nomenclature
of airway secretory cells based on
morphologic characteristics may need to be
revisited.
Our in vivo finding that CCSP1 cells in
small airways have the capacity to produce
MUC5B was supported by in vitro LAE and
SAE cell culture data. Interestingly, airway
epithelial cells isolated from large and
small airway regions were differentiated
into phenotypes that maintained region-
specific characteristics when cultured
under identical conditions. This result
recapitulates the previous findings that
proximal and distal airway basal cells
exhibited region-specific gene expression
profiles and progenitor properties during
lung regeneration in mice (46, 65).
There are limitations to our
morphologic studies. First, the study group
was small, particularly for the RNA ISH and
immunohistochemistry studies, because of
the strict inclusion criteria used to select
normal/healthy lungs. Second, it is possible
that degranulation of the stored mucin
protein from superficial epithelial cells
occurred during the tissue isolation, which
might result in underestimation of AB-PAS-
and mucin protein–stained volumes
compared with those in vivo. However,
MUC5B and MUC5AC localization
patterns obtained from RNA ISH were
consistent with carbohydrate/protein
localization data, suggesting degranulation
may not have occurred (Figure 3).
Moreover, we tested whether expression of
forkhead box A3 (FOXA3), a transcription
factor typically expressed in goblet cells
(66), might be helpful in addressing this
question. Immunohistochemistry
experiments revealed positive signals for
FOXA3 protein in the nuclei of goblet
cells in airway epithelium with GMH,
whereas FOXA3 staining was absent in
normal/healthy airway epithelium (see
Figure E12). These data, therefore, suggest
that the “normal/healthy” airway
epithelium with less AB-PAS–stained area
did not contain the degranulated goblet
cells. Finally, the affinity of probes for RNA
ISH differed for MUC5AC and MUC5B.
Direct measurements of relative RNA ISH
MUC5B versus MUC5AC probe affinities in
gene-edited A549 cells, however, provided a
useful correction factor. Collectively, the
RNA ISH quantitation of MUC5AC and
MUC5B, the absolute mucin transcript
expression data by ddPCR in freshly
isolated airway surface epithelium, and
the cell culture data all agreed that MUC5B
is the dominant expressed and secreted
mucin in distal human superficial airway
epithelia.
In conclusion, MUC5B is extensively
expressed in human airway superficial
epithelia in addition to SMG. The distal
airway region is the major site for MUC5B
production in the superficial epithelium of
the human lung. MUC5AC is normally only
produced by the superficial epithelia of the
cartilaginous larger airways. Both MUC5B
and MUC5AC are colocalized in CCSP1
cells in proximal superficial epithelium,
whereas MUC5B is colocalized in CCSP1
cells of distal airway superficial epithelia.
Our study suggests an important
contribution to mucin secretion by the
superficial epithelium of the distal airways
that are the initial site of mucus plugging in
mucoobstructive and possibly IPF
diseases. n
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